Antitope

 

Immunogenicity testing and protein engineering

Antitope is pioneering a new generation of immunogenicity testing, antibody humanization and protein engineering technologies. Our mission is to apply these technologies to create improved non-immunogenic biologics.

Formed in 2004, Antitope offer proprietary technologies as a comprehensive service for evaluating immunogenicity, identifying T cell epitopes, producing humanized antibodies and generating non-immunogenic proteins.

The core proprietary technologies include:

EpiScreen™ for accurately measuring the immunogenicity potential of therapeutic proteins and different formulations, identifying specific T cell epitopes or determining the potential of NCEs to induce late onset allergy like reactions.

Composite Human Antibodies™ to generate humanized, T cell epitope depleted antibodies for therapeutic use.

Composite Proteins™ to generate non-immunogenic proteins with desired biological function for therapeutic use.

 

Latest news

29 February 2008
28 February 2008 Antitope Ltd (Cambridge, UK), a leader in the generation of ...
20 February 2008
  Antitope to Present at 2nd Annual Conference on Recombinant Antibodies ...


Copyright © 2007 Antitope Ltd. All rights reserved.